Leonard M Blum's Net Worth
$12.7 Million
Who is Leonard M Blum?
Leonard M Blum has an estimated net worth of $12.7 Million. This is based on reported shares across multiple companies, which include THERAVANCE INC, Theravance Biopharma, Inc., EyePoint Pharmaceuticals, Inc., and ICOS CORP / DE.
SEC CIK
Leonard M Blum's CIK is 0001222247
Past Insider Trading and Trends
2004 was Leonard M Blum's most active year for acquiring shares with 6 total transactions. Leonard M Blum's most active month to acquire stocks was the month of January. 2007 was Leonard M Blum's most active year for disposing of shares, totalling 6 transactions. Leonard M Blum's most active month to dispose stocks was the month of December. 2008 saw Leonard M Blum paying a total of $307,698.45 for 71,996 shares, this is the most they've acquired in one year. In 2007 Leonard M Blum cashed out on 325,000 shares for a total of $4,587,614.90, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
THERAVANCE INC (INVA) Snapshot price: $18.7201
Sr VP, Chief Comm. OfficerLeonard M Blum owns 401,538 units of Common Stock which is worth $7,516,831.51.acquired a total of 446,563 shares in THERAVANCE INC at a cost of $440,713.86, Leonard also disposed a total of 45,025 shares of THERAVANCE INC equalling to $1,203,930.75.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.81% | -3.26K |
$22.76 | -$74,220.36 | 401.54K |
Aug 20
| |||
Form 4
| +7.54% | 28.36K |
—
|
—
| 404.8K |
Jun 16
| |||
Form 4
| +23.25% | 71K |
—
|
—
| 376.43K |
Jun 2
| |||
Form 4
| -5.81% | -18.85K |
$26.86 | -$506,284.14 | 305.43K |
May 9
| |||
Form 4
| +13.08% | 37.5K |
—
|
—
| 324.28K |
Apr 27
| |||
Form 4
| -1.48% | -4.31K |
$39.98 | -$172,353.78 | 286.78K |
Feb 20
| |||
Form 4
| +1.75% | 5K |
—
|
—
| 291.09K |
Jul 24
| |||
Form 4
| -1.14% | -3.29K |
$37.01 | -$121,836.92 | 286.09K |
May 20
| |||
Form 4
| +1.76% | 5K |
—
|
—
| 289.39K |
Feb 7
| |||
Form 4
| +1.79% | 5K |
—
|
—
| 284.39K |
Oct 15
| |||
Form 4
| -2.63% | -7.55K |
$29.69 | -$224,040.74 | 279.39K |
Jul 30
| |||
Form 4
| +1.77% | 5K |
—
|
—
| 286.93K |
Feb 15
| |||
Form 4
| +66.40% | 112.5K |
—
|
—
| 281.93K |
Feb 11
| |||
Form 4
| +7.97% | 12.5K |
—
|
—
| 169.43K |
Oct 26
| |||
Form 4
| -1.06% | -1.69K |
$13.02 | -$21,951.72 | 156.93K |
May 20
| |||
Form 4
| +8.71% | 12.7K |
$10.47 | $133,015.41 | 158.62K |
Feb 24 - Feb 25
| |||
Form 4
| -0.91% | -1.33K |
$10.22 | -$13,643.70 | 145.92K |
Feb 20
| |||
Form 4
| +20.45% | 25K |
—
|
—
| 147.25K |
Feb 10
| |||
Form 4
| -0.90% | -1.11K |
$14.04 | -$15,640.56 | 122.25K |
Nov 20
| |||
Form 4
| -0.87% | -1.08K |
$15.65 | -$16,964.60 | 123.36K |
Aug 20
| |||
Form 4
| -0.87% | -1.09K |
$14.06 | -$15,269.16 | 124.45K |
May 20
| |||
Form 4
| +38.66% | 35K |
—
|
—
| 125.53K |
Mar 20
| |||
Form 4
| -1.59% | -1.46K |
$14.87 | -$21,725.07 | 90.53K |
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 4
| +44.62% | 28.39K |
$10.84 | $307,698.45 | 92K |
Mar 10
| |||
Form 4
| +27.22% | 13.61K |
—
|
—
| 63.61K |
Jan 29
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.01
Sr VP, Chief Comm. OfficerLeonard M Blum owns 182,731 units of Ordinary Shares which is worth $1,463,675.31. In the year 2014 Leonard M Blum filed a total of 8 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.10% | -16.10K |
$15.65 | -$251,980.65 | 182.73K |
Feb 20
| |||
Form 4
| -0.47% | -934.00 |
$12.98 | -$12,123.32 | 198.83K |
Aug 20
| |||
Form 4
| -3.55% | -7.36K |
$13.83 | -$101,788.80 | 199.77K |
Jun 2
| |||
Form 4
| -0.32% | -673.00 |
$14.24 | -$9,583.52 | 207.13K |
May 20
| |||
Form 4
| -0.32% | -674.00 |
$19.52 | -$13,156.48 | 207.8K |
Feb 20
| |||
Form 4
| +75.97% | 90K |
—
|
—
| 208.47K |
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EyePoint Pharmaceuticals, Inc. (EYPT) Snapshot price: $7.97
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ICOS CORP / DE No price found
Senior VP, Sales and MarketingLeonard M Blum used to own units in Common Stock but no longer holds any shares there.acquired a total of 73,400 shares in ICOS CORP / DE at a cost of $331,989.00, Leonard also disposed a total of 86,400 shares of ICOS CORP / DE equalling to $2,937,542.90.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -92.63K |
$34.00 | -$3,149,386.00 |
0
|
Jan 29
| |||
Form 4
| -0.66% | -571.00 |
$33.90 | -$19,356.90 | 85.83K |
Jan 24
| |||
Form 4
| +9.89% | 8K |
$22.30 | $178,360.00 | 88.9K |
Jun 13
| |||
Form 4
| +9.54% | 7K |
—
|
—
| 80.4K |
Jan 24
| |||
Form 4
| +1.38% | 1K |
$27.97 | $27,970.00 | 73.4K |
Dec 29
| |||
Form 4
| +316.09% | 55K |
—
|
—
| 72.4K |
Jul 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
| +12.26% | 1.9K |
$39.69 | $75,411.00 | 17.4K |
Feb 19
| |||
Form 4
| +10.34% | 1.5K |
$40.16 | $60,230.00 | 16K |
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
| +11.54% | 1.5K |
$36.48 | $54,723.00 | 14.5K |
Aug 20
| |||
| No matching records found | |||||||||